Table 1.
No. | ID | Age | Sex | Sample* | Localization† | TNM (clinical, 7th edition) | Stage | Treatment |
---|---|---|---|---|---|---|---|---|
1 | p40 | 80 | Female | 1 | 3 | T4N2bM0 | 4 | RT |
2 | p42 | 68 | Female | 1 | 1 | T2N0M0 | 2 | RT, OP |
3 | p14 | 77 | Female | 2 | 2 | T2N1M0 | 2 | RT, OP |
4 | p24 | 64 | Male | 2 | 1 | T1N0M0 | 1 | OP |
5 | p29 | 64 | Female | 2 | 2 | T2N0M0 | 2 | RT |
6 | p68 | 62 | Male | 2 | 1 | T2N0M0 | 2 | OP, RT |
7 | p70 | 71 | Male | 2 | 2 | T1N0M0 | 1 | OP, RT |
8 | p82 | 19 | Female | 2 | 2 | T4N0M0 | 4 | RT, OP |
9 | p83 | 64 | Female | 2 | 2 | T1N0M0 | 1 | OP |
10 | p92 | 63 | Female | 2 | 2 | T2N0M0 | 2 | RT, OP, CYT |
11 | p11 | 78 | Male | 3 | 2 | T2N0M0 | 2 | RT, OP |
12 | p35 | 24 | Female | 3 | 1 | T2N0M0 | 2 | RT, OP |
13 | p49 | 52 | Female | 3 | 3 | T4N2cM0 | 4 | RT |
14 | p51 | 74 | Male | 3 | 1 | T2N0M0 | 2 | RT, OP |
15 | p56 | 40 | Female | 3 | 3 | T2N2bM0 | 3 | RT, OP |
16 | p58 | 61 | Male | 3 | 1 | T1N0M0 | 1 | OP |
17 | p59 | 68 | Female | 3 | 1 | T2N0M0 | 2 | RT, OP |
18 | p61 | 69 | Male | 3 | 3 | T4aN0M0 | 4 | RT |
19 | p65 | 81 | Female | 3 | 3 | T2N0M0 | 2 | OP, RT |
20 | p73 | 80 | Male | 3 | 3 | T4aN0M0 | 4 | RT |
21 | p76 | 58 | Male | 3 | 3 | T4aN0M0 | 4 | RT |
22 | p79 | 60 | Male | 3 | 2 | T1N0M0 | 1 | RT, OP |
23 | p85 | 87 | Female | 3 | 1 | T2N0M0 | 2 | OP, RT |
24 | p98 | 31 | Male | 3 | 3 | T2N0M0 | 2 | OP, RT |
25 | p105 | 63 | Male | 3 | 2 | T1N0M0 | 1 | RT, OP |
26 | p111 | 31 | Female | 3 | 2 | T1N0M0 | 1 | OP, RT |
27 | p119 | 66 | Male | 3 | 2 | T2N0M0 | 2 | OP, RT |
28 | p124 | 54 | Male | 3 | 3 | T4aN2bM0 | 4 | RT |
29 | p131 | 74 | Female | 3 | 2 | T2N0M0 | 2 | OP, RT |
30 | p137 | 71 | Female | 3 | 2 | T2N0M0 | 2 | RT, OP |
31 | p138 | 50 | Male | 3 | 2 | T2N1M0 | 2 | RT, OP |
CYT, cytostatics; OP, operation; RT, radiotherapy.
1 = only tumor‐free sample, 2 = only tumor sample, 3 = tumor‐free and tumor samples were collected.
1 = tongue, 2 = lateral border of the tongue, 3 = tongue with overgrowth outside the mobile tongue.